Adenovirus Current Events | Adenovirus News
|
|
|
Sort By:
Page Views | Date |
Quick technique to identify adenoviruses can improve patient care
Grantees of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have adapted a rapid and accurate new molecular typing strategy and used it to conduct one of the most comprehensive studies of adenoviruses ever performed in the United States. view more (2007-10-12)
Gamma globulin effective in treating eye infections caused by adenoviruses
Gamma globulin, a type of antibody isolated from blood samples that used to be routinely given to health care workers and international travelers to protect them from infectious diseases, is a highly effective treatment for pinkeye with little apparent toxicity, according to a study by researchers at the University of Pittsburgh School of Medicine. view more (2007-08-29)
New Vaccine Developed for Preventing 'Uncommon Cold' Virus
Common colds typically cause a week of sneezing, aches and pains and then fade away leaving only a sore nose and a few used sick days behind. But what if that cold turned out to be something more? view more (2009-02-03)
Researchers pit novel version of common virus against cancer
With nearly $1 million in government funding, University of Rochester scientists are testing a new innovation in biotherapy by altering a common childhood respiratory virus, the adenovirus, to destroy cancer cells. view more (2007-06-21)
Three-in-one virus killer prevents common, often fatal infections
A novel combination therapy drastically reduces the infection rate of three viruses - and risk of death - in transplant patients with compromised immune systems. view more (2006-10-27)
First evidence of gene therapy for abnormal blood vessel growth in newborns
The first evidence of the potential for gene therapy to treat eye disease that stems from abnormal blood vessel growth is revealed in research published in the British Journal of Ophthalmology. Gene therapy is a relatively new and much heralded therapeutic approach. But despite the advances in molecular genetics, attempts to target organs or... view more... (2001-07-18)
Adenoviral vector specifically targeted to EphA2 receptor in pancreatic cancer cells
Pancreatic cancer is a devastating disease with poor prognosis. This warrants the development of novel therapies including gene therapy. view more (2009-06-24)
Gene therapy appears safe to regenerate gum tissue
Scientists at the University of Michigan have developed a method of gene delivery that appears safe for regenerating tooth-supporting gum tissue-a discovery that assuages one of the biggest safety concerns surrounding gene therapy research and tissue engineering. view more (2009-04-08)
In blood vessel stents, innovative materials allow better control, delivery of gene therapy
Before gene therapy becomes practical for treating human diseases, researchers must master the details of safe and effective delivery. view more (2008-04-16)
Protein analysis methods, viral vectors featured in Cold Spring Harbor Protocols
Many proteins do not function by themselves as stand-alone units. Instead, multiple proteins associate to form larger structures called protein complexes. view more (2009-05-05)
Bare metal stents deliver gene therapy to heart vessels with less inflammation in animal studies
Improved materials may allow stents, tiny metal scaffolds inserted into blood vessels, to better deliver beneficial genes to patients with heart disease, by reducing the risk of inflammation that often negates initial benefits. view more (2005-12-20)
Progress made in HIV vaccine development
Researchers have successfully tested two candidate vaccines that may eventually be used together to confer immunity against HIV infection. Their findings are published in the December 15 issue of The Journal of Infectious Diseases, now available online. view more (2006-11-13)
Contagious obesity? Identifying the human adenoviruses that may make us fat
Human adenoviruses may cause human obesity, but more research is needed before a screening test and vaccine become reality. view more (2006-01-30)
Signal protein shows promise for blocking tumor promoters in skin cells
A protein with the ironic name "Srcasm" can counteract the effects of tumor-promoting molecules in skin cells, according to new research by investigators at the University of Pennsylvania School of Medicine. view more (2006-11-06)
Gene therapy increases survival for end-stage head and neck cancer
A gene therapy invented at The University of Texas M. D. Anderson Cancer Center is the first to succeed in a U.S. phase III clinical trial for cancer, as announced today at the American Society of Gene Therapy annual meeting in Boston. view more (2008-05-29)
Study shows liver an excellent target for cancer gene therapy using viral vectors
A featured paper in the February 14 issue of Nature Cancer Gene Therapy demonstrates that cancer cells in the liver are excellent targets for gene therapy using adenoviral vectors, based upon a fundamental new understanding of the differences between cancerous and normal liver cells. view more (2007-02-15)
T cell-based HIV vaccine candidate demonstrates positive results
The question of whether or not to continue to pursue the development of T-cell-based HIV-1 vaccines has been a source of controversy following last year's widely publicized failure of the field's most promising candidate, a vaccine developed by Merck known as V520. view more (2008-11-10)
Targeted virus compels cancer cells to eat themselves
An engineered virus tracks down and infects the most common and deadly form of brain cancer and then kills tumor cells by forcing them to devour themselves, researchers at The University of Texas M. D. Anderson Cancer Center report this week in the Journal of the National Cancer Institute. view more (2006-05-03)
Vaccine provides 100 percent protection against avian flu virus in animal study
University of Pittsburgh researchers announced they have genetically engineered an avian flu vaccine from the critical components of the deadly H5N1 virus that completely protected mice and chickens from infection. view more (2006-01-27)
How HIV vaccine might have increased odds of infection
In September 2007, a phase II HIV-1 vaccine trial was abruptly halted when researchers found that the vaccine may have promoted, rather than prevented, HIV infection. view more (2008-11-03)
|
|
|
|
Sort By:
Page Views | Date |
|
